Transcatheter liver lobar ablation: an experimental trial in an animal model.
Complete embolization of tumor tissue together with surrounding liver sufficiently prevents collateral blood supply to the tumor, offering curative treatment for hepatic malignancies. The present experiment was designed to test the feasibility of hepatic lobar ablation by means of the transcatheter chemoembolization technique. Five groups of rats (n = 6) were treated with a mixture of iodized oil/ethanol in ratios of 5:1, 4:1, 3:1, 1:1, and 1:0, which was injected selectively into the right-lobe artery until saturation during open surgery. Another group (n = 6) was studied using in vivo microscopy to observe the distribution of the mixture in the liver and changes in hepatic microcirculation. Ethiodol/ethanol mixture entered the portal vein after injection into the hepatic artery creating dual, complete arterial and portal venous embolization. Lobar ablation effects were achieved in 2 weeks in the 5:1, 4:1, and 3:1 ratio groups, indicated by the lobe/liver weight measurements (p < 0.001 vs normal liver). Hepatic arterial administration of the Ethiodol/ethanol mixture creates dual hepatic arterial and portal venous embolization, achieving a lobar ablation effect.
Kan
Z
Z
Department of Diagnostic Radiology, Box 057, The University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
Wallace
S
S
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage; D002404:Catheterization; D016461:Chemoembolization, Therapeutic / Q000379:methods*; D000431:Ethanol / Q000008:administration & dosage; D004998:Ethiodized Oil / Q000008:administration & dosage; D006499:Hepatic Artery; D008099:Liver / Q000473:pathology*; D008102:Liver Circulation; D008833:Microcirculation; D011169:Portal Vein; D051381:Rats; D017207:Rats, Sprague-Dawley
D000970:Antineoplastic Agents; D000431:Ethanol; D004998:Ethiodized Oil